3701-7-10 Maternity homes: infection control.

(A) All persons whose work or service responsibilities involve continuing activities in the maternity home, including the formula room, shall have a health evaluation by a licensed physician or other licensed health professional operating within their scope of practice, which shall include establishing the absence of conditions transmissible to others, prior to their having access to the home. This evaluation shall include a test for tuberculosis in accordance with paragraph (D) of this rule.

(B) The maternity home shall establish and follow written infection control policies and procedures for the surveillance, control and prevention, and reporting of communicable disease organisms by both the contact and airborne routes which shall be consistent with current infection control guidelines issued by the United States centers for disease control and prevention. The policies and procedures shall address:

(1) The utilization of protective clothing and equipment;

(2) The storage, maintenance and distribution of sterile supplies and equipment;

(3) The disposal of biological waste, including blood, body tissue, and fluid in accordance with Ohio law;

(4) Universal precautions body substance isolation or equivalent; and

(5) Tuberculosis and other airborne diseases.

(C) The maternity home shall not knowingly permit a staff member to provide services if the staff member has a communicable disease capable of being transmitted during the performance of his or her duties.

(D) The maternity home shall require each staff member to be tested for tuberculosis in accordance with this paragraph.

(1) The required tuberculosis test shall include a single blood assay for M. tuberculosis (BAMT) test, or the two-step Mantoux test for tuberculosis using five tuberculin units of purified protein derivative or, if the individual has a documented history of a significant BAMT test, or Mantoux test, a chest x-ray shall be done upon hire.

(a) If the first skin test is nonsignificant, the staff member may have resident contact while waiting for the results of a second skin test. A second skin test shall be performed at least seven, but not more than twenty-one, days after the first step was performed. If the second test is nonsignificant, a single test shall be repeated annually within thirty days of the anniversary date of the most recent testing. The individual shall not have any resident contact until after the results of the BAMT test, or first step of the Mantoux test have been obtained and recorded in millimeters of induration. Only a single step Mantoux or BAMT test is required if the individual has documentation of either a single step Mantoux test or a two-step Mantoux or BAMT test within one year of commencing work.

(b) The first step of the Mantoux test should be read within forty-eight to seventy-two hours following application. If the first step in the Mantoux test is nonsignificant, a second step shall be performed at least seven, but not more than twenty-one, days after the first step was performed.

(c) If the tuberculosis testing performed pursuant to paragraphs (D)(1)(a) and (D)(1)(b) of this rule is nonsignificant, a single Mantoux or BAMT test shall be performed annually within thirty days of the anniversary date of the most recent testing. Individuals with a documented history of a significant BAMT test or Mantoux test shall be assessed annually within thirty days of the anniversary date of the most recent testing or assessment.

(d) If either step of the Mantoux test, or the BAMT test, is significant, the maternity home shall take action consistent with guidelines issued by the United States centers for disease control and prevention for the prevention of tuberculosis. Additional tuberculosis testing is not required after one medically documented significant test.

(2) Maternity homes shall retain documentation evidencing compliance with this paragraph and shall furnish such documentation to the director upon request.

(E) The maternity home shall comply with rule 3701-3-03 of the Administrative Code pertaining to reportable disease notification.

Effective: 08/01/2008

R.C. 119.032 review dates: 03/26/2008 and 03/01/2013

Promulgated Under: 119.03

Statutory Authority: 3701.34, 3711.02

Rule Amplifies: 3711.04, 3711.05, 3711.06

Prior Effective Dates: 7/15/1976, 4/30/03